Arkema | AKE - Sales Revenues

Stock Price
61.70
Daily Change
0 0%
Monthly
11.57%
Yearly
-6.52%
Q2 Forecast
60.29

Arkema reported EUR2.11B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Air Products & Chemicals USD 3.1B 70M Dec/2025
Air Liquide EUR 13.22B 6.62B Dec/2025
Akzo Nobel EUR 2.39B 20M Mar/2026
Arkema EUR 2.11B 80M Dec/2025
BASF EUR 14.03B 300M Dec/2025
Bayer EUR 11.44B 1.78B Dec/2025
Covestro EUR 2.92B 255M Dec/2025
Croda International GBP 825.73M 412.23M Dec/2025
Givaudan CHF 3.61B 256M Dec/2025
IMCD EUR 1.1B 100M Dec/2025
Johnson Matthey GBP 1.28B 4.76B Sep/2025
Kemira EUR 677M 13M Mar/2026
Lenzing EUR 630.43M 468K Dec/2025
Linde USD 8.76B 149M Dec/2025
PPG Industries USD 3.86B 50M Mar/2026
Sika AG CHF 5.52B 151.5M Dec/2025
Solvay EUR 995M 45M Dec/2025
Umicore EUR 10.68B 8.89B Dec/2025